Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
- PMID: 29069747
- PMCID: PMC5641090
- DOI: 10.18632/oncotarget.17894
Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
Abstract
The distribution pattern of renal cell carcinoma (RCC) histological subtypes according to age, gender and tumor size has not been well illustrated in RCC patients living in fast-developing regions of China. We recruited 2941 patients with clear cell renal cell carcinoma (ccRCC), papillary renal cell carcinoma (PCC) or chromophobe from two hospitals in coastal China (2004-2012) consecutively and draw 538 American Chinese RCC patients' data with time matched from the Surveillance, Epidemiology, and End Results database. We found that compared with ccRCC patients, chromophobe patients were more likely to be female (OR: 2.538, 95% CI: 1.923-3.350), younger (OR for 51-60 years old: 0.686; OR for over 60 years old: 0.478; reference: age < 50) and to have a larger maximal diameter (Dmax) (OR for Dmax > 7 cm: 1.883; reference: Dmax ≤ 4 cm). Besides, in comparison with coastal Chinese patients, American Chinese individuals had lower Fuhrman grades (P < 0.001) and had an onset age 10 years delay. In conclusion, we were the first to observe marked gender, age and tumor size differences in the proportional subtype distribution of RCCs in coastal Chinese patients, and also the first to compare coastal Chinese with American Chinese data.
Keywords: Chinese; SEER; distribution; histological subtype; renal cell carcinoma.
Conflict of interest statement
CONFLICTS OF INTERESTS The author(s) indicated no potential conflicts of interest.
Figures


Similar articles
-
Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.Int Urol Nephrol. 2017 Feb;49(2):215-224. doi: 10.1007/s11255-016-1460-3. Epub 2016 Nov 16. Int Urol Nephrol. 2017. PMID: 27853915
-
Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.Eur Urol. 2005 Oct;48(4):593-600. doi: 10.1016/j.eururo.2005.04.016. Eur Urol. 2005. PMID: 15964127
-
A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.Am J Surg Pathol. 2010 Sep;34(9):1233-40. doi: 10.1097/PAS.0b013e3181e96f2a. Am J Surg Pathol. 2010. PMID: 20679882
-
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.Urology. 2004 Sep;64(3):462-7. doi: 10.1016/j.urology.2004.04.016. Urology. 2004. PMID: 15351571 Review.
-
Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.Int Urol Nephrol. 2016 Feb;48(2):191-9. doi: 10.1007/s11255-015-1161-3. Epub 2015 Nov 20. Int Urol Nephrol. 2016. PMID: 26589610 Review.
Cited by
-
Comparative analysis of histopathological subtypes of renal cell carcinoma in the Middle East compared to other world regions.Urol Ann. 2021 Apr-Jun;13(2):130-133. doi: 10.4103/UA.UA_172_20. Epub 2021 Mar 4. Urol Ann. 2021. PMID: 34194138 Free PMC article.
-
Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.Exp Biol Med (Maywood). 2021 Mar;246(6):729-739. doi: 10.1177/1535370220977107. Epub 2020 Dec 10. Exp Biol Med (Maywood). 2021. PMID: 33302735 Free PMC article.
-
Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma.Onco Targets Ther. 2018 Sep 6;11:5535-5544. doi: 10.2147/OTT.S171881. eCollection 2018. Onco Targets Ther. 2018. PMID: 30233214 Free PMC article.
-
Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma.Front Oncol. 2019 Mar 19;9:152. doi: 10.3389/fonc.2019.00152. eCollection 2019. Front Oncol. 2019. PMID: 30941304 Free PMC article.
-
Epidemiology and Treatment Outcomes of Renal Cell Carcinoma in Qassim Region, Saudi Arabia: A Retrospective Study.Cureus. 2024 Oct 31;16(10):e72748. doi: 10.7759/cureus.72748. eCollection 2024 Oct. Cureus. 2024. PMID: 39618569 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. - PubMed
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–386. - PubMed
-
- Guo J, Ma J, Sun Y, Qin S, Ye D, Zhou F, He Z, Sheng X, Bi F, Cao D, Chen Y, Huang Y, Liang H, et al. Chinese guidelines on the management of renal cell carcinoma (2015 edition) Chin Clin Oncol. 2016;5:12. - PubMed
-
- Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. - PubMed
-
- Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol. 2003;170:2163–2172. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources